Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population
Journal of Drugs in Dermatology · 01.11.2026 · 25 (11) · 1077-1079
DOI: 10.36849/jdd.9785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.10.2026. Verfasst von Mojahed Mohammad K Shalabi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shalabi, M. M. K., Talasila, S., Malick, H., Jeha, G. M., & Tolkachjov, S. N. (2026). Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population. Journal of Drugs in Dermatology, 25(11), 1077-1079. https://doi.org/10.36849/jdd.9785
Vancouver
Shalabi MMK, Talasila S, Malick H, Jeha GM, Tolkachjov SN. Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population. Journal of Drugs in Dermatology. 2026;25(11):1077-1079. doi:10.36849/jdd.9785
BibTeX
@article{Shalabi2026,
author = {Shalabi, Mojahed Mohammad K and Talasila, Sahithi and Malick, Hamza and Jeha, George M and Tolkachjov, Stanislav N},
title = {Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {11},
pages = {1077--1079},
doi = {10.36849/jdd.9785}
}
EUVIMED